 | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | ? |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.014.761 |
| Chemical and physical data | |
| Formula | C16H21NO |
| Molar mass | 243.350 g·mol−1 |
Norlevorphanol is an opioid analgesic of the morphinan family that was never marketed.[2] It is the levo-isomer of 3-hydroxymorphinan (morphinan-3-ol). Norlevorphanol is a Schedule I Narcotic controlled substance in the United States with an ACSCN of 9634 and in 2014 it had an annual aggregate manufacturing quota of 52 grams. It is used as the hydrobromide (free base conversion ratio 0.750) and hydrochloride (0.870).[3]
See also
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- ^ http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html
 | This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
 | This stereochemistry article is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 6 October 2023, at 08:11